272 related articles for article (PubMed ID: 30405107)
1. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.
Lin W; Yip YL; Jia L; Deng W; Zheng H; Dai W; Ko JMY; Lo KW; Chung GTY; Yip KY; Lee SD; Kwan JS; Zhang J; Liu T; Chan JY; Kwong DL; Lee VH; Nicholls JM; Busson P; Liu X; Chiang AKS; Hui KF; Kwok H; Cheung ST; Cheung YC; Chan CK; Li B; Cheung AL; Hau PM; Zhou Y; Tsang CM; Middeldorp J; Chen H; Lung ML; Tsao SW
Nat Commun; 2018 Nov; 9(1):4663. PubMed ID: 30405107
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation.
Yip YL; Lin W; Deng W; Jia L; Lo KW; Busson P; Vérillaud B; Liu X; Tsang CM; Lung ML; Tsao SW
Lab Invest; 2018 Aug; 98(8):1093-1104. PubMed ID: 29769697
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma.
Hsu CL; Lui KW; Chi LM; Kuo YC; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Lu YJ; Hsieh CH; Chang KP; Tsang NM; Wang HM; Chang AY; Chang YS; Li HP
J Exp Clin Cancer Res; 2018 Sep; 37(1):233. PubMed ID: 30236142
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
5. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
6. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
7. EBV reactivation as a target of luteolin to repress NPC tumorigenesis.
Wu CC; Fang CY; Hsu HY; Chuang HY; Cheng YJ; Chen YJ; Chou SP; Huang SY; Lin SF; Chang Y; Tsai CH; Chen JY
Oncotarget; 2016 Apr; 7(14):18999-9017. PubMed ID: 26967558
[TBL] [Abstract][Full Text] [Related]
8. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
9. Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells.
Fang CY; Lee CH; Wu CC; Chang YT; Yu SL; Chou SP; Huang PT; Chen CL; Hou JW; Chang Y; Tsai CH; Takada K; Chen JY
Int J Cancer; 2009 May; 124(9):2016-25. PubMed ID: 19132751
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus.
Raab-Traub N
Curr Top Microbiol Immunol; 2015; 390(Pt 1):339-63. PubMed ID: 26424653
[TBL] [Abstract][Full Text] [Related]
12. BHRF1 Enhances EBV Mediated Nasopharyngeal Carcinoma Tumorigenesis through Modulating Mitophagy Associated with Mitochondrial Membrane Permeabilization Transition.
Song S; Jiang Z; Spezia-Lindner DE; Liang T; Xu C; Wang H; Tian Y; Bai Y
Cells; 2020 May; 9(5):. PubMed ID: 32392902
[TBL] [Abstract][Full Text] [Related]
13. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
Hui KF; Cheung AK; Choi CK; Yeung PL; Middeldorp JM; Lung ML; Tsao SW; Chiang AK
Int J Cancer; 2016 Jan; 138(1):125-36. PubMed ID: 26205347
[TBL] [Abstract][Full Text] [Related]
15. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
16. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
